• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Artikel
  4. Rating sputum cell quality in clinical trials for asthma and COPD treatment
 
  • Details
  • Full
Options
2019
Journal Article
Title

Rating sputum cell quality in clinical trials for asthma and COPD treatment

Abstract
Background: Induced sputum is a method to assess airway inflammation in clinical trials for asthma and COPD.1-3 Sputum is a heterogeneous, viscous material containing inflammatory cell plugs, cellular debris, mucus, and saliva with squamous cells. The quality of sputum cell preparations for differential cell count analysis depends on multiple factors and can be highly variable.4,5 Percentage of squamous cell contamination (SQ%) is often used to assess the quality of sputum cell preparations.6Here, we evaluated a comprehensive quality score,7 which also includes an assessment of the inflammatory cell morphology and amount of cellular debris.
Author(s)
Pedersen, Frauke
Zissler, Ulrich M.
Watz, Henrik
Rabe, Klaus F.
Hohlfeld, Jens M.
Holz, Olaf  
Journal
International journal of chronic obstructive pulmonary disease  
Open Access
DOI
10.2147/COPD.S188033
Additional link
Full text
Language
English
Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM  
  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024